In clinical practice, GLP‐1 receptor (GLP‐1R) agonists are used as medications to treat diabetes by enhancing GLP‐1R signalling and promoting insulin release from pancreatic islets.19 This evidence concerns the gene GLP1R and diabetes mellitus.